Literature DB >> 9302809

The impact of Hymenoptera venom allergy on occupational activities.

E Kahan1, R Ben-Moshe, E Derazne, R Tamir.   

Abstract

The objective of this study was to investigate the impact of allergy to hymenoptera venom on the occupational activities of patients undergoing immunologic treatment for insect sting anaphylaxis. The design was a cross-sectional study conducted in a sample of 500 out of 1,500 patients undergoing venom immunotherapy for insect sting reaction in 13 allergy clinics in Israel. A self-administered questionnaire was used to collect data about demographic characteristics of patients, severity of the allergic reaction and adverse effects on occupational activities. Of the 204 respondents who were part of the labour force, 48.5% reported adverse effects on routine occupational activities. The factors with a significant influence on the probability of adverse occupational effects were: (1) patient's type of work (blue collar vs. white collar: OR = 3.22, p < 0.001: army vs. white collar: OR = 5.28, p = 0.001); (2) severity of the allergic reaction (severe reaction vs. mild/moderate reaction: OR = 2.34, p = 0.007). Our findings suggest that severe insect sting allergy has an adverse impact on patients' occupational activities. This factor requires special attention by the medical community. Social workers and occupational physicians should collaborate in the assessment and management of these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9302809     DOI: 10.1093/occmed/47.5.273

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  2 in total

1.  Hymenoptera sting reactions in southern Italy forestry workers: our experience compared to reported data.

Authors:  Luisa Ricciardi; Francesco Papia; Giuseppe Cataldo; Mario Giorgianni; Giovanna Spatari; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2018-04-17

2.  Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy.

Authors:  Giulia Paolocci; Ilenia Folletti; Kjell Torén; Giacomo Muzi; Nicola Murgia
Journal:  BMJ Open       Date:  2014-08-06       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.